Global Regulation of Nucleotide Biosynthetic Genes by C-Myc
Overview
Authors
Affiliations
Background: The c-Myc transcription factor is a master regulator and integrates cell proliferation, cell growth and metabolism through activating thousands of target genes. Our identification of direct c-Myc target genes by chromatin immunoprecipitation (ChIP) coupled with pair-end ditag sequencing analysis (ChIP-PET) revealed that nucleotide metabolic genes are enriched among c-Myc targets, but the role of Myc in regulating nucleotide metabolic genes has not been comprehensively delineated.
Methodology/principal Findings: Here, we report that the majority of genes in human purine and pyrimidine biosynthesis pathway were induced and directly bound by c-Myc in the P493-6 human Burkitt's lymphoma model cell line. The majority of these genes were also responsive to the ligand-activated Myc-estrogen receptor fusion protein, Myc-ER, in a Myc null rat fibroblast cell line, HO.15 MYC-ER. Furthermore, these targets are also responsive to Myc activation in transgenic mouse livers in vivo. To determine the functional significance of c-Myc regulation of nucleotide metabolism, we sought to determine the effect of loss of function of direct Myc targets inosine monophosphate dehydrogenases (IMPDH1 and IMPDH2) on c-Myc-induced cell growth and proliferation. In this regard, we used a specific IMPDH inhibitor mycophenolic acid (MPA) and found that MPA dramatically inhibits c-Myc-induced P493-6 cell proliferation through S-phase arrest and apoptosis.
Conclusions/significance: Taken together, these results demonstrate the direct induction of nucleotide metabolic genes by c-Myc in multiple systems. Our finding of an S-phase arrest in cells with diminished IMPDH activity suggests that nucleotide pool balance is essential for c-Myc's orchestration of DNA replication, such that uncoupling of these two processes create DNA replication stress and apoptosis.
PRPS activity tunes redox homeostasis in Myc-driven lymphoma.
MacMillan A, Karki B, Yang J, Gertz K, Zumwalde S, Patel J bioRxiv. 2025; .
PMID: 39868212 PMC: 11761749. DOI: 10.1101/2025.01.08.632009.
Pham T, Kim M, Nguyen T, Park J, Kim J, Seo J Int J Biol Sci. 2025; 21(2):772-788.
PMID: 39781465 PMC: 11705630. DOI: 10.7150/ijbs.104458.
da Silva Fernandes T, Gillard B, Dai T, Martin J, Chaudhry K, Dugas S Sci Rep. 2025; 15(1):1061.
PMID: 39774345 PMC: 11707137. DOI: 10.1038/s41598-024-85094-5.
Survival Impacts of Mitochondrial Status in Esophageal Squamous Cell Carcinoma Patients.
Sugawara K, Sakashita S, Fukuda T, Murakami C, Oka D, Amori G Ann Surg Oncol. 2024; 32(3):1963-1972.
PMID: 39645554 PMC: 11811432. DOI: 10.1245/s10434-024-16533-w.
Alterations in the proteomes of HepG2 and IHKE cells inflicted by six selected mycotoxins.
Keuter L, Fortmann M, Behrens M, Humpf H Arch Toxicol. 2024; 99(2):701-715.
PMID: 39638853 PMC: 11775057. DOI: 10.1007/s00204-024-03905-0.